Ethics of early clinical trials in regenerative medicine in transplantation | Online, Thursday 3 February 2022
Bio-artificial organs and bio-engineered or bio-printed tissues for transplantation in humans are rapidly being developed. It is anticipated that some applications will be ready for clinical testing in the near future. How can first-in-human clinical trials be conducted in a safe and responsible manner? What are ethical points to consider for early clinical trials of regenerative medicine in transplantation? This workshop brings together experts in the fields of regenerative medicine and ethics to discuss these ethical challenges.
This video shows the full recording of the VANGUARD Ethics workshop held online, Thursday 3 February 2022 from 16:00–18:00.
Below is a list of all accepted VANGUARD scientific publications available to date. Further publications as well as conference posters, proceedings and presentations will be added when available.c
VANGUARD continuously reports its results and progress to the European Commission. Some of these reports (called “Deliverables”) are public and once submitted are made available for download here.
* Please note that these deliverables are undergoing review and acceptance processes. At this stage this deliverable reflects only the author’s view and the European Commission is not responsible for any use that may be made of the information it contains.